Institutional Ownership
Eikon Therapeutics Inc
CUSIP 282564103COMQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
48
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 18, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 3.84M | $40.59M |
| 2 | Blackrock, Inc. | 3.32M | $35.12M |
| 3 | Foresite Capital Management IV, LLC | 1.94M | $20.56M |
| 4 | Merck & Co., Inc. | 1.67M | $17.63M |
| 5 | Foresite Capital Management V, LLC | 1.32M | $13.95M |
| 6 | Capital World Investors | 1.14M | $12.10M |
| 7 | Alliancebernstein L.P. | 1.02M | $10.81M |
| 8 | Ecor1 Capital, LLC | 732.6K | $7.75M |
| 9 | Baker Bros. Advisors LP | 555.6K | $5.88M |
| 10 | Soros Capital Management LLC | 484.7K | $5.13M |